New meta-analysis demonstrates that high-flux haemodialysis may reduce cardiovascular mortality by 17% compared with low-flux haemodialysis
Cardiovascular and non-cardiovascular mortality rates for people commencing haemodialysis are nearly 30 to 50 times higher than for the general population. It has been suggested that removal of larger solutes across high-flux haemodialysis membranes may better reflect normal kidney function and improve cardiovascular outcomes versus low-flux haemodialysis. Here we report results from a meta-analysis investigating this hypothesis.
To view the full article, click here.
Fresenius Medical Care screens current renal publications and offers summaries for medical healthcare professionals. To view the latest renal summary, please click here.
If you’d like to see additional renal publications that have been in focus recently, please click here.
Click on the links below to access a number of guidelines.
By using a link, you will leave the Fresenius Medical Care Indonesia website. Fresenius Medical Care does not take any responsibility for the content of the linked websites.